XTX Topco’s Health Catalyst HCAT Stock Holding History

XTX Topco’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71.3K	Buy	56,130 +44,128	+368%	+$83K	﹤0.01%	3218
2025 Q4	$28.7K	Sell	12,002 -53,417	-82%	-$146K	﹤0.01%	2977
2025 Q3	$186K	Buy	+65,419	New	+$224K	0.01%	1874
2025 Q2	–	Sell	-11,845	Closed	-$53.7K	–	2685
2025 Q1	$53.7K	Buy	+11,845	New	+$62.7K	﹤0.01%	1993
2024 Q4	–	Sell	-18,727	Closed	-$152K	–	2536
2024 Q3	$152K	Sell	18,727 -9,693	-34%	-$70K	0.01%	1517
2024 Q2	$182K	Buy	28,420 +9,248	+48%	+$59.4K	0.02%	1276
2024 Q1	$144K	Buy	+19,172	New	+$175K	0.02%	1271
2023 Q4	–	Sell	-12,064	Closed	-$122K	–	1791
2023 Q3	$122K	Sell	12,064 -2,975	-20%	-$35.5K	0.02%	1155
2023 Q2	$188K	Buy	+15,039	New	+$179K	0.03%	1029
2023 Q1	–	Sell	-17,690	Closed	-$188K	–	1436
2022 Q4	$188K	Sell	17,690 -6,451	-27%	-$62.3K	0.04%	870
2022 Q3	$234K	Buy	+24,141	New	+$320K	0.06%	675
2021 Q3	–	Sell	-5,088	Closed	-$282K	–	828
2021 Q2	$282K	Sell	5,088 -805	-14%	-$42.9K	0.1%	396
2021 Q1	$276K	Buy	+5,893	New	+$285K	0.13%	314

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

CDC Financial Chicago, Illinois $157M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco's HCAT Position: Q1 2026 in Review

XTX Topco increased its Health Catalyst (HCAT) stake by 368% in Q1 2026, buying an estimated $83K and bringing the position to 56,130 shares worth $71.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

XTX Topco first reported a position in HCAT in Q1 2021 and has held it in 13 quarters since. The position peaked at $282K in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

XTX Topco held 56,130 shares of Health Catalyst worth $71.3K as of Q1 2026.
XTX Topco bought 44,128 Health Catalyst shares in Q1 2026, an estimated $83K.
Health Catalyst made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3218 holding.
XTX Topco first reported a position in Health Catalyst in Q1 2021 and has held it in 13 quarters since.
XTX Topco's Health Catalyst position peaked at $282K in Q2 2021.
130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.